Fig. 1From: A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancerSynthesis of 2-butyryl oxy-5-butylaminyl benzoic acid (BBA) as the dual-prodrug of butyric acid (BA) and 5-aminosalicylic acid (5-ASA)Back to article page